Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
TCT 23: AGENT IDE
Author(s): Robert Yeh Added: 1 year ago
TCT 23 - In this short online interview, we are joined by Dr Robert Yeh (Beth Israel Deaconess Medical Center, US) to discuss the findings of the AGENT IDE trial (NCT04647253), sponsored by Boston Scientific. AGENT IDE is a prospective, 2:1 randomized multicenter trial that aimed to compare the AGENT paclitaxel-coated balloon to plain-old balloon angioplasty (POBA) with a commercially available… View more

Intervention
Job title: Clinical Professor of Medicine and Pharmacology
Yield and Characterisation of CFT in ANOCA
Author(s): Johanna McChord , Astrid Hubert , Udo Sechtem , et al Added: 6 months ago

Prevention & Chronic Conditions
Job title: Professor of Anesthesiology and Physiology
Portrait image of Mehak Dhande
Research Area(s) / Expertise:

Electrophysiology & Arrhythmia

 Job title: Faculty Clinical Instructor
Dr Dhande is an interventional cardiac electrophysiologist at University of Pittsburgh Medical Center, with a master's degree in clinical informatics and management from Stanford University School of Medicine. She is a physician scientist leading international studies to test patient facing applications of generative AI agents, in collaboration with Heart Rhythm Society. As an advisor and… View more
TCT 23: 5 Trials That Changed My Practice
Author(s): Mirvat Alasnag Added: 1 year ago
TCT 23 - We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of the late-breaking trials that are expected to have an impact on interventional science and clinical practice. Trials covered in detail include: Agent IDE ALIGN-AR PARTNER 3 EVOLUT Low-Risk TRISCEND Recorded remotely from Jeddah, 2023. Editor: Jordan Rance Video Specialist:… View more

Intervention
TCT 23: 5 Trials That Will Change My Practice
Author(s): Bernardo Cortese Added: 1 year ago
TCT 23 - We are joined by Dr Bernardo Cortese (Ospedale Fate bene Fratelli, IT) for a concise and insightful summary of the late-breaking trials that are expected to have an impact on structural heart disease care.Trials covered in detail include:PARTNER 3Evolut Low RiskLIFE-BTKAGENT-IDETRANSFORM IRecorded remotely from Milano, 2023.Editor: Jordan RanceVideo Specialist: Dan Brent View more

Vascular Disease and Surgery

Intervention
View from the Thoraxcenter: TCT 23 Late-breaking Science Wrap Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 year ago
What are the top late-breaking trials from #TCT2023? TCT 2023 — Join interventional cardiologists, Prof Nicolas Van Mieghem and Dr Joost Daemen from the Thoraxcenter as they unpack the most impactful late-breaking clinical trials and science data from this year's Transcatheter Cardiovascular Therapeutics Conference. Dive into this practical and engaging discussion and learn more about the… View more

Intervention
View from the Thoraxcenter: TCT 23 Late-breaking Science Preview
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 1 year ago
What's hot at TCT 2023? In this episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, NL) preview the late-breaking data presented at TCT 2023. With their dynamic analysis, these anticipated trials are placed in context, highlighting the real-world implications tied to the data releases. Top trials covered: 00:31 - 02:12: PARTNER 3 Low… View more

Intervention
Johanne Silvain
Research Area(s) / Expertise: Job title: Prof. Johanne Silvain is professor of medicine at the Pierre and Marie Curie University in Paris, France.
He is an interventional cardiologist, with experience in coronary angioplasty and OTC, and is Director of the Coronary Intensive Care Unit.He is licensed at the University of Medicine of Paris (UPMC) and is the author of over 100 publications in prestigious authoritative journals.The research interests of Dr. Silvain fall within the field of thrombosis (composition of thrombi) and antithrombotic… View more